We found a modest but significant (protective) association of the APOE ε2 allele with cognitive status in our cohort, with higher ε2 dosage conferring a lower (but small) risk of self-declared cognitive impairment in individuals with PD. This evidence concerns the gene APOE and Parkinson disease.